Filter
315
Text search:
Pfizer
Featured
Recommendations
41
New Publications
17
Language
Document type
No document type
79
Guidelines
73
Studies & Reports
64
Fact sheets
41
Manuals
16
Strategic & Response Plan
15
Resource Platforms
8
Situation Updates
5
Training Material
4
Videos
4
Infographics
3
Online Courses
3
Countries / Regions
Brazil
14
Russia
11
Germany
9
Argentina
9
Global
9
South Africa
8
Ukraine
7
Middle East and North Africa
7
Latin America and the Carribbean
7
Mozambique
6
India
5
Chile
5
Africa
5
Ecuador
4
Senegal
3
China
3
Colombia
3
East and Southern Africa
3
West and Central Africa
3
Western and Central Europe
3
Paraguay
3
Liberia
2
Nigeria
2
Uganda
2
Philippines
2
Kenya
2
Indonesia
2
Peru
2
El Salvador
2
Congo, Democratic Republic of
1
Guinea-Bissau
1
Ghana
1
Somalia
1
Nepal
1
South Sudan
1
Syria
1
Chad
1
Tanzania
1
Sudan
1
Benin
1
Angola
1
Yemen
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Eastern Europe
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Iran
1
Kazakhstan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
104
Clinical Guidelines
20
Women & Child Health
7
Public Health
6
Key Resources
4
Annual Report MEDBOX
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
154
Mental Health
30
TB
16
HIV
15
NTDs
14
AMR
12
Refugee
8
NCDs
8
Global Health Education
6
Disability
4
Health Financing Toolbox
4
Rapid Response
3
Caregiver
3
Pharmacy
3
Ebola
1
Conflict
1
Zika
1
Planetary Health
1
This guideline covers identifying, assessing and managing the long-term effects of COVID-19, often described as ‘long COVID’. It makes recommendations about care in all healthcare settings for adults, children and young people who have new or ongoing symptoms 4 weeks or more after the start of a
...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition
...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Lancet Public health 2022 January 6, 2022 https://doi.org/10.1016/ S2468-2667(21)00249-8
Growth in the number of individuals living with dementia underscores the need for public health planning efforts and policy to address the needs of this group. Country-level estimates can be used to inform nati
...
Strategic Plan for COVID-19 vaccination in Argentina
Considerations on the implementation and adjustment of
public health and social measures in the context of
COVID-19
Interim guidance 14 June 2021
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
SOBRE ESTE GUIA
Este é um guia de referência rápida que resume as recomendações da Superintendência de Atenção Primária (S/SUBPAV/SAP) para o diagnóstico e o manejo na atenção primária da infecção pelo novo coronavírus. O documento representa o posicionamento da S/SUBPAV/SAP e tem a
...
Frequently asked questions on COVID-19 vaccination. Version 6, 12 February 2022
(Last Update: July 2022)
The African Centers for Disease Control and Prevention and the African Union together have called for a New Public Health Order which will safeguard the health and economic security of the continent as it strives to meet the aspirations of the Agenda 2063. A key pillar of this mandate seeks to expan
...
Technical Guidelines for SARS-CoV-2 Vaccination: Third version
O Informe Semanal de Evidências sobre Variantes de Atenção do SARS-CoV-2 é uma produção organizada pelo Departamento de Ciência e Tecnologia da Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde do Ministério da Saúde (DECIT/SCTIE/MS). O documento tem o objetiv
...
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed
to support decision making. A countrywide mass vaccination campaign with the
use of an inactivated severe acute respiratory syndrome c
...
Resumen ejecutivo guía de práctica clínica manejo de la infección por Sars-CoV 2
